FDA Adverse Event Injury Summary report: N

COOLSCULPTING SYSTEM

MDR report key: 21763997 · Received April 3, 2025

Report

Report Number
3007215625-2025-00233
Event Type
Injury
Date Received
April 3, 2025
Report Date
April 7, 2025
Manufacturer
ALLERGAN PLEASANTON
Product Code
OOK
PMA / PMN Number
K160259
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

CORRECTION: SUBSEQUENT TO THE SUBMISSION OF INITIAL MEDWATCH, THIS REPORT HAS BEEN IDENTIFIED AS A DUPLICATE OF PREVIOUSLY SUBMITTED MEDWATCH REPORT OF 33007215625-2025-00234-00.

Additional Manufacturer Narrative · 0

PARADOXICAL ADIPOSE HYPERPLASIA (PH) IS A KNOWN POTENTIAL ADVERSE EVENT ADDRESSED IN THE PRODUCT LABELING. ACCORDING TO THE COOLSCULPTING USER MANUAL, UNDER RARE ADVERSE EVENTS, PH IS CHARACTERIZED BY A VISIBLY ENLARGED TISSUE VOLUME WITHIN THE TREATMENT AREA, WHICH MAY DEVELOP TWO TO FIVE MONTHS AFTER TREATMENT. SURGICAL INTERVENTION MAY BE REQUIRED. PH IS NOT RELATED TO ANY COOLSCULPTING DEVICE FAILURE MODE BUT IT IS INCLUDED IN THE RISK MANAGEMENT FILES OF THE DEVICE BECAUSE IT IS A RISK THAT IS INHERENT TO THE USE CRYOLIPOLYSIS FOR LOCALIZED FAT REDUCTION. A SUPPLEMENTAL REPORT WILL BE SUBMITTED IF AND WHEN ADDITIONAL INFORMATION IS OBTAINED.

Description of Event or Problem · 0

CORRECTION: SUBSEQUENT TO THE SUBMISSION OF INITIAL MEDWATCH, THIS REPORT HAS BEEN IDENTIFIED AS A DUPLICATE OF PREVIOUSLY SUBMITTED MEDWATCH REPORT OF 33007215625-2025-00234-00. PER PROCESSING, CANCELLING (B)(4) AS A DUPLICATE OF (B)(4). MDR WILL BE CANCELLED.

Description of Event or Problem · 0

ALLERGAN AESTHETICS RECEIVED A REPORT OF A PATIENT TREATED WITH COOLSCULPTING ELITE SYSTEM TO THE ABDOMEN AREA AND INDICATED POSSIBLE PARADOXICAL HYPERPLASIA (PH).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1445543 COOLSCULPTING SYSTEM DERMAL COOLING PACK/VACUUM/MASSAGER OOK ALLERGAN PLEASANTON NI

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Required Intervention